advancing early drug discovery (pdfs)/icagen_iddflyer.pdfadvancing early drug discovery icagen...
TRANSCRIPT
ADVANCING EARLY DRUG DISCOVERY
Icagen Corporate Headquarters4222 Emperor Blvd, Suite 350Durham, NC 27703
+1 919-941-5206
Email us: [email protected]
Icagen-T Inc.2090 E. Innovation Park DriveOro Valley, AZ 85755
+1 520-544-6800
Visit us at: www.icagen.com
A Target-to-Lead Partner
Icagen’s integrated approach is at the core of everything we do, positioning us as a comprehensive partner across early drug discovery. Employing specific expertise in medicinal chemistry with highly-specialized methodologies in computational chemistry, ultra-high throughput screening, and drug discovery biology, we wholly support our partners to determine drug feasibility and generate viable leads with unprecedented speed. Our in-house capabilities span multiple disciplines, but are united in the common goal of advancing early drug discovery programs.
Synthetic Chemistry
Medicinal Chemistry
Selectivity Profiling
Potency/Selectivity Optimization
Computational Modeling
in vitro Pharmacology
Efficacy in Patient Cells
Animal Models
in vitro Early ADME
Human Disease Models
Mechanism of Action
Pharmacokinetics/ Pharmacodynamics
Drug Interaction/ Metabolism Studies
in silico Screening
High Throughput Screening
High Content Screening
Orthogonal Screening
Active Series Expansion
Early Discovery Lead Optimization
Target Credentialing
Patient Cell Model Development
Custom Library Creation
Assay Creation
in silico Target Assessment
Hit Identification Hit to Lead
Icagen advances early drug discovery through industry-leading experience, taking many different target classes to advanced leads.
INTEGRATED DRUG DISCOVERY